Literature DB >> 24527062

Cytomegalovirus infection in childhood-onset systemic lupus erythematosus.

Evelyn V Rozenblyum1, Upton D Allen2, Earl D Silverman3, Deborah M Levy3.   

Abstract

Systemic lupus erythematosus (SLE) is a multisystem disease with significant morbidity and even mortality. Cytomegalovirus (CMV) is a ubiquitous herpesvirus that, similar to SLE, can also lead to significant morbidity and mortality in the immunocompromised host. The relationship between SLE and CMV is complex, with observations suggesting that CMV induces the autoimmunity of SLE in addition to occurring in the immunocompromised host with known SLE. In this article, we first consider CMV infection in the immunocompetent host, and further examine how this infection differs in the patient with SLE. We focus on disease mechanisms, CMV detection and treatment. We review the differences between CMV infection, syndrome and disease, as identifying the correct state will determine the appropriate treatment. We propose guidelines for the screening and management of CMV infection in childhood-onset SLE, and recognize that further study in this population is required to increase our understanding of the interplay between these disease entities.

Entities:  

Keywords:  CMV; Cytomegalovirus; childhood; complication; detection; guidelines; infection; lupus; pediatric

Year:  2013        PMID: 24527062      PMCID: PMC3920748          DOI: 10.2217/ijr.12.82

Source DB:  PubMed          Journal:  Int J Clin Rheumtol        ISSN: 1758-4280


  64 in total

1.  Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients.

Authors:  Atul Humar; Tony Mazzulli; George Moussa; Raymund R Razonable; Carlos V Paya; Mark D Pescovitz; Emma Covington; Emma Alecock
Journal:  Am J Transplant       Date:  2005-05       Impact factor: 8.086

2.  Exploring the complex relationships between infections and autoimmunity.

Authors:  Andrea Doria; Sandra Zampieri; Piercarlo Sarzi-Puttini
Journal:  Autoimmun Rev       Date:  2008-08-24       Impact factor: 9.754

3.  Fatal cytomegalovirus infection in two patients with systemic lupus erythematosus undergoing intensive immunosuppressive therapy: role for cytomegalovirus vigilance and prophylaxis?

Authors:  Kam Hon Yoon; Kok Yong Fong; Paul Ananth Tambyah
Journal:  J Clin Rheumatol       Date:  2002-08       Impact factor: 3.517

Review 4.  Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

Authors:  Maher K Gandhi; Rajiv Khanna
Journal:  Lancet Infect Dis       Date:  2004-12       Impact factor: 25.071

5.  Cytomegalovirus infection in pediatric rheumatic diseases: a review.

Authors:  Eli M Eisenstein; Dana G Wolf
Journal:  Pediatr Rheumatol Online J       Date:  2010-05-20       Impact factor: 3.054

6.  Cytomegalovirus seroprevalence and childhood sources of infection: A population-based study among pre-adolescents in the United States.

Authors:  Stephanie A S Staras; W Dana Flanders; Sheila C Dollard; Robert F Pass; John E McGowan; Michael J Cannon
Journal:  J Clin Virol       Date:  2008-09-07       Impact factor: 3.168

7.  Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.

Authors:  Giuseppe Gerna; Fausto Baldanti; Maria Torsellini; Lorenzo Minoli; Mario Viganò; Tiberio Oggionnis; Teresa Rampino; Barbara Castiglioni; Antonio Goglio; Michele Colledan; Carmelo Mammana; Francesca Nozza; Lilleri Daniele
Journal:  Antivir Ther       Date:  2007

Review 8.  Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

Authors:  M Boeckh; G Boivin
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

9.  Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies.

Authors:  Peter D Burbelo; Alexandra T Issa; Kathryn H Ching; Maurice Exner; W Lawrence Drew; Harvey J Alter; Michael J Iadarola
Journal:  Virol J       Date:  2009-05-01       Impact factor: 4.099

10.  Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.

Authors:  Claudia Azucena Palafox Sánchez; Minoru Satoh; Edward Kl Chan; Wendy C Carcamo; José Francisco Muñoz Valle; Gerardo Orozco Barocio; Edith Oregon Romero; Rosa Elena Navarro Hernández; Mario Salazar Páramo; Antonio Cabral Castañeda; Mónica Vázquez Del Mercado
Journal:  Arthritis Res Ther       Date:  2009-02-20       Impact factor: 5.156

View more
  6 in total

1.  Evaluation of a multiplex PCR assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis.

Authors:  Saifun Nahar; Atsushi Iraha; Akira Hokama; Ayako Uehara; Gretchen Parrott; Tetsuya Ohira; Masatoshi Kaida; Tetsu Kinjo; Takeshi Kinjo; Tetsuo Hirata; Nagisa Kinjo; Jiro Fujita
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

2.  Systemic lupus erythematous revealed by cytomegalovirus infection.

Authors:  Rezgui Amel; Karmani Monia; Mzabi Anis; Ben Fredj Fatma; Laouani Chadia
Journal:  Pan Afr Med J       Date:  2016-07-15

3.  Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR.

Authors:  Kyoung Yong Lee; Byung-Woo Yoo; Sung Soo Ahn; William Han Bae; Hyukmin Lee; Seung Min Jung; Sang-Won Lee; Yong-Beom Park; Jason Jungsik Song
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

Review 4.  CD28 null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection.

Authors:  Aalia Bano; Alejandra Pera; Ahmad Almoukayed; Thomas H S Clarke; Sukaina Kirmani; Kevin A Davies; Florian Kern
Journal:  F1000Res       Date:  2019-03-25

5.  Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience.

Authors:  Jingtao Cui; Wenjuan Yan; Hongjie Xie; Shaoxia Xu; Qiaofeng Wang; Weihong Zhang; Anping Ni
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240

6.  Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.